A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung Academic Article uri icon

Overview

MeSH Major

  • Adenoviridae
  • Clinical Trials, Phase I as Topic
  • Cystic Fibrosis
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Gene Transfer Techniques
  • Genetic Therapy

publication date

  • January 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7578401

Additional Document Info

start page

  • 643

end page

  • 66

volume

  • 6

number

  • 5